15-45116501-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_207581.4(DUOXA2):c.341-15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.868 in 1,613,064 control chromosomes in the GnomAD database, including 625,633 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.71 ( 45109 hom., cov: 33)
Exomes 𝑓: 0.88 ( 580524 hom. )
Consequence
DUOXA2
NM_207581.4 intron
NM_207581.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.550
Genes affected
DUOXA2 (HGNC:32698): (dual oxidase maturation factor 2) This gene encodes an endoplasmic reticulum protein that is necessary for proper cellular localization and maturation of functional dual oxidase 2. Mutations in this gene have been associated with thyroid dyshormonogenesis 5.[provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 15-45116501-C-T is Benign according to our data. Variant chr15-45116501-C-T is described in ClinVar as [Benign]. Clinvar id is 263303.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-45116501-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.896 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUOXA2 | ENST00000323030.6 | c.341-15C>T | intron_variant | Intron 3 of 5 | 1 | NM_207581.4 | ENSP00000319705.5 | |||
DUOXA2 | ENST00000491993.2 | n.*408-15C>T | intron_variant | Intron 3 of 5 | 1 | ENSP00000454110.1 | ||||
DUOXA2 | ENST00000350243.10 | n.621-15C>T | intron_variant | Intron 3 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.711 AC: 108005AN: 151980Hom.: 45122 Cov.: 33
GnomAD3 genomes
AF:
AC:
108005
AN:
151980
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.853 AC: 211951AN: 248430Hom.: 93928 AF XY: 0.865 AC XY: 116767AN XY: 134938
GnomAD3 exomes
AF:
AC:
211951
AN:
248430
Hom.:
AF XY:
AC XY:
116767
AN XY:
134938
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.885 AC: 1292681AN: 1460966Hom.: 580524 Cov.: 50 AF XY: 0.888 AC XY: 645306AN XY: 726778
GnomAD4 exome
AF:
AC:
1292681
AN:
1460966
Hom.:
Cov.:
50
AF XY:
AC XY:
645306
AN XY:
726778
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.710 AC: 107991AN: 152098Hom.: 45109 Cov.: 33 AF XY: 0.719 AC XY: 53482AN XY: 74364
GnomAD4 genome
AF:
AC:
107991
AN:
152098
Hom.:
Cov.:
33
AF XY:
AC XY:
53482
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2798
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Thyroglobulin synthesis defect Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at